£885.00

New to our records — first sighting 27 days ago. We'll learn its rhythm.

27 days of data · current price £885

2026-2031 World Outlook for Macular Degeneration Treatments

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 5 days · 5 data points (no recent data)

Historical
Generating forecast…
£885.00 £840.75 £858.45 £876.15 £893.85 £911.55 £929.25 24 September 2026 25 September 2026 26 September 2026 27 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 23 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 5 days • 1 price levels

Days at Price
5 days 0 1 3 4 5 £885 Days at Price

Price Analysis

Most common price: £885 (5 days, 100.0%)

Price range: £885 - £885

Price levels: 1 different prices over 5 days

Description

This comprehensive market analysis provides strategic insight into the global landscape of macular degeneration treatments through 2031, examining therapeutic developments, regional demand patterns, and industry opportunities. Published by ICON Group International, Inc., the report delivers data-driven forecasts and trend analysis for healthcare professionals, pharmaceutical companies, and investors seeking to understand how treatment options for age-related macular degeneration and other forms of macular disease are evolving across major markets. The five-year outlook equips readers with intelligence on emerging therapies, competitive positioning, and patient needs to inform business strategy and investment decisions in this vital segment of ophthalmology and eye care.

Key Features

Covers the period 2026-2031 with forward-looking market forecasts for macular degeneration treatment options worldwide.

Provides regional analysis and demand projections across key geographic markets for therapeutic interventions.

Examines competitive landscape and emerging treatment modalities in the macular degeneration sector.

Supports strategic planning for healthcare stakeholders, pharmaceutical manufacturers, and healthcare investors.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
04 June 2025
Listed Since
05 August 2025

Similar Products You Might Like

2026-2031 World Outlook for Retinal Disorder Treatments
98% match

2026-2031 World Outlook for Retinal Disorder Treatments

£885.00 28 Sep 2026
The 2026-2031 World Outlook for Opthalmologies
96% match

The 2026-2031 World Outlook for Opthalmologies

£885.00 13 Sep 2026
The 2026-2031 World Outlook for Lysosomal Storage Diseases Treatments
96% match

The 2026-2031 World Outlook for Lysosomal Storage Diseases Treatments

£885.00 21 Oct 2026
The 2026-2031 World Outlook for Ophthalmology Ambulatory Healthcare Services
95% match

The 2026-2031 World Outlook for Ophthalmology Ambulatory Healthcare Services

£885.00 22 Sep 2026
The 2026-2031 World Outlook for Infectious Disease Treatments
95% match

The 2026-2031 World Outlook for Infectious Disease Treatments

£885.00 22 Sep 2026
The 2026-2031 World Outlook for Opthalmology Surgery Devices
95% match

The 2026-2031 World Outlook for Opthalmology Surgery Devices

£885.00 13 Sep 2026
The 2026-2031 World Outlook for Clinical Optical Imaging Devices
95% match

The 2026-2031 World Outlook for Clinical Optical Imaging Devices

£885.00 31 Aug 2026
The 2026-2031 World Outlook for Chronic Obstructive Pulmonary Disease Treatments
95% match

The 2026-2031 World Outlook for Chronic Obstructive Pulmonary Disease Treatments

£885.00 16 Oct 2026
The 2026-2031 World Outlook for Lysosomal Storage Diseases Therapeutics
95% match

The 2026-2031 World Outlook for Lysosomal Storage Diseases Therapeutics

£885.00 21 Oct 2026
The 2026-2031 World Outlook for Biophotonics
95% match

The 2026-2031 World Outlook for Biophotonics

£885.00 30 Aug 2026
The 2026-2031 World Outlook for Nuclear Medicine Therapeutics
95% match

The 2026-2031 World Outlook for Nuclear Medicine Therapeutics

£885.00 22 Sep 2026
The 2026-2031 World Outlook for Soil Treatments
95% match

The 2026-2031 World Outlook for Soil Treatments

£885.00 15 Oct 2026
The 2021-2026 World Outlook for Eye Exams
95% match

The 2021-2026 World Outlook for Eye Exams

£795.00 15 Oct 2026
The 2026-2031 World Outlook for Oligonucleotide Therapeutics
95% match

The 2026-2031 World Outlook for Oligonucleotide Therapeutics

£885.00 21 Oct 2026
The 2026-2031 World Outlook for Oligonucleotide Therapeutics for Neurological Disorders
95% match

The 2026-2031 World Outlook for Oligonucleotide Therapeutics for Neurological Disorders

£885.00 29 Aug 2026
The 2026-2031 World Outlook for Pulmonary Fibrosis Treatments
95% match

The 2026-2031 World Outlook for Pulmonary Fibrosis Treatments

£885.00 28 Sep 2026
The 2026-2031 World Outlook for Clostridium Difficile Treatments
95% match

The 2026-2031 World Outlook for Clostridium Difficile Treatments

£885.00 28 Sep 2026
The 2026-2031 World Outlook for Optical Imaging
95% match

The 2026-2031 World Outlook for Optical Imaging

£885.00 22 Sep 2026
The 2026-2031 World Outlook for Neurostimulation
95% match

The 2026-2031 World Outlook for Neurostimulation

£885.00 22 Sep 2026
The 2026-2031 World Outlook for Optical Character Recognition
94% match

The 2026-2031 World Outlook for Optical Character Recognition

£885.00 30 Aug 2026
The 2026-2031 World Outlook for Medication Management
94% match

The 2026-2031 World Outlook for Medication Management

£885.00 13 Sep 2026
The 2026-2031 World Outlook for Lysosomal Storage Diseases
94% match

The 2026-2031 World Outlook for Lysosomal Storage Diseases

£885.00 29 Aug 2026
The 2026-2031 World Outlook for Exocrine Pancreatic Insufficiency Therapeutics
94% match

The 2026-2031 World Outlook for Exocrine Pancreatic Insufficiency Therapeutics

£885.00 07 Aug 2026
The 2026-2031 World Outlook for Deep Brain Stimulation Systems
94% match

The 2026-2031 World Outlook for Deep Brain Stimulation Systems

£885.00 16 Oct 2026